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were characterized as stx2/stx2vh-a
by PCR-restriction fragment length
polymorphism. 
To our knowledge, this is the first
HUS case in our country in which the
source of infection was identified. No
investigation was conducted to trace
back the source of the ground beef.
This study illustrates the importance
of the surveillance of STEC infections
and the usefulness of molecular
subtyping techniques, such as PFGE
and phage typing, to determine the
relatedness of strains and assess
epidemiologic associations. 
The public should be made aware
that hamburgers, even when prepared
at home, can be a source of infection.
A primary strategy for preventing
infection with E. coli O157:H7 is
reducing risk behaviors through
consumer education (10).
Acknowledgments
We thank Patricia Griffin for her
review and helpful comments on earlier
draft.
This work was supported by grants
from Centers for Disease Control and
Prevention (USA) and Fundación Alberto
J. Roemmers (Argentina).
Marta Rivas,* María Gracia Caletti,†
Isabel Chinen,* Stella Maris Refi,‡
Carlos Daniel Roldán,† 
Germán Chillemi,* 
Graciela Fiorilli,† Alicia Bertolotti,‡
Lorena Aguerre,* 
and Sergio Sosa Estani§ 
*Instituto Nacional de Enfermedades
Infecciosas-ANLIS “Dr. Carlos G. Malbrán,”
Buenos Aires, Argentina.; †Hospital
Nacional de Pediatría “Prof. Dr. Juan
Garrahan,” Buenos Aires, Argentina;
‡Laboratorio Central de Salud Pública, La
Plata, Argentina; and §Centro Nacional de
Diagnóstico e Investigación en Endemo-
epidemias-ANLIS “Dr. Carlos G. Malbrán,”
Buenos Aires, Argentina
References
1. Comité de Nefrología de la Sociedad
Argentina de Pediatría. Incidencia del
síndrome urémico hemolítico (SUH) en la
República Argentina. Arch Arg Pediatr
1995;93:409–11.
2. Gianantonio CA, Vitacco M, Mendilaharzu
F, Rutty A, Mendilaharzu J. The hemolytic-
uremic syndrome. J Pediatr
1964;64:478–91.
3. Spizzirri FD, Rahman RC, Bibiloni N,
Ruscasso JD, Amoreo OR. Childhood
hemolytic uremic syndrome in Argentina:
long-term follow-up and prognostic fea-
tures. Pediatr Nephrol 1997;11:156–60.
4. Miliwebsky ES, Balbi L, Gomez D,
Wainsztein R, Cueto Rua M, Roldan C, et
al. Síndrome urémico hemolítico en niños
de Argentina: asociación con la infección
por  Escherichia coli productor de toxina
Shiga. Bioq Patol Clin 1999;63:113–21.
5. Griffin PM, Tauxe R. The epidemiology of
infections caused by Escherichia coli
O157:H7, other enterohemorrhagic E. coli
and the associated hemolytic uremic syn-
drome. Epidemiol Rev 1991;13:60–98.
6. Pollard DR, Johnson WM, Lior H, Tyler
SD, Rozee KR. Rapid and specific detec-
tion of verotoxin genes in Escherichia coli
by the polymerase chain reaction. J Clin
Microbiol 1990;28:540–5.
7. Paton A, Paton J. Detection and
characterization of Shiga toxigenic
Escherichia coli by using multiplex PCR
assays for stx1, stx2, eaeA,
enterohemorrhagic E. coli hlyA, rfbO111,
and  rfbO157. J Clin Microbiol
1998;36:598–602. 
8. Heuvelink AE, Zwartkruis-Nahuis JTM, De
Boer E. Evaluation of media and test kits
for the detection and isolation of
Escherichia coli O157 from minced beef. J
Food Prot 1997;60:817–24.
9. Chinen I, Tanaro JD, Miliwebsky E, Lound
LH, Chillemi G, Ledri S, et al. Isolation and
characterization of Escherichia coli
O157:H7 from retail meats in Argentina. J
Food Prot 2001;64:1346–51.
10. Griffin PM, Mead P, Sivapalasingam S.
Escherichia coli O157:H7 and other entero-
hemorrhagic  Escherichia coli. In: Blaser
MJ, Smith PD, Ravdin JI, Greenberg HB,
Guerrant RL, editors. Infections of the gas-
trointesinal tract, 2nd edition. Philadelphia:
Lippincott Williams and Wilkins; 2002. p.
627–42.
Address for correspondence: Marta Rivas,
Servicio Fisiopatogenia, Instituto Nacional de
Enfermedades Infecciosas-ANLIS “Dr. Carlos
G. Malbrán,” Av. Vélez Sarsfield 563 (1281),
Buenos Aires, Argentina; fax: +54-11-4303-
1801; email: mrivas@anlis.gov.ar
Q Fever in Thailand 
To the Editor: Coxiella burnetii, a
strict intracellular bacterium, is the
etiologic agent of Q fever, a world-
wide zoonosis. Humans are infected
by inhaling contaminated aerosols
from amniotic fluid or placenta or
handling contaminated wool (1). The
bacterium is highly infectious by the
aerosol route. Two forms of the dis-
ease are typical: acute and chronic.
Acute Q fever is the primary infection
and in specific hosts may become
chronic (1,2). The major clinical man-
ifestations of acute Q fever are pneu-
monia and hepatitis. Less common
clinical manifestations are aseptic
meningitis and/or encephalitis, pan-
creatitis, lymphadenopathy that mim-
ics lymphoma, erythrema nodosum,
bone marrow necrosis, hemolytic ane-
mia, and splenic rupture (2). The main
clinical manifestation of the chronic
form is culture-negative endocarditis,
but infection of vascular grafts or
aneurysms, hepatitis, osteomyelitis,
and prolonged fever have also been
described (1,2). Fluoroquinolones,
co-trimoxazole, and doxycycline are
active against C. burnetii in vitro, and
ceftriaxone has been shown to have a
bacteriostatic effect and could be
effective in the phagolysosome of C.
burnetii–infected cells (3). However,
the treatment of choice for Q fever is
doxycycline. 
The incidence of this disease is
largely unknown, especially in Asia.
Q fever has been reported from Japan
and China (1). Seroepidemiologic sur-
veys have shown that subclinical
infection is common worldwide.
Large outbreaks of Q fever have also
been reported in many countries in
Europe (4). A case series of acute Q
fever was diagnosed in a prospective
study in patients with acute febrile ill-
ness who were admitted to four hospi-
tals in northeastern Thailand:
Udornthani Hospital, Udornthani
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vince; Loei Hospital, Loei Province;
and Banmai Chaiyapod Hospital,
Bureerum Province. Two serum sam-
ples were taken from these patients,
on admission and at a 2- to 4-week
outpatient follow-up visit, and stored
at –20°C until serologic tests were
performed at the Faculty of Medicine
Siriraj Hospital, Mahidol University,
and the National Research Institute of
Health, Public Health Ministry of
Thailand. All serum samples were
tested for the serologic diagnosis of
leptospirosis, scrub typhus, murine
typhus, and dengue infection as previ-
ously described (5,6). After these
serologic tests were performed, serum
samples from patients with unknown
diagnosis were sent for the serologic
test for Q fever at Unité des
Rickettsies, Faculté de Médecine,
Marseille, France. The microimmuno-
fluorescent antibody test, using a
panel antigen of C. burnetii,
Rickettsial honei, R. helvetica, R.
japonica, R. felis, R. typhi, Bartonella
henselae, B. quintana, Anaplasma
phagocytophila, and Orientia tsutsug-
amushi, was used as described previ-
ously (6). 
A total of 1,171 serum specimens
from 678 patients were tested for Q
fever. Nine  patients (1.3%, eight male
and one female) fulfilled the diagno-
sis of acute Q fever. The median age
was 42 (range 15–62) years. All
patients were rice farmers, and their
farm animals were chicken and cattle.
The median duration of fever was 3
(range 1–7) days before admission
into the hospital. When initially seen,
all patients had acute febrile illness,
headache, and generalized myalgia
(i.e., a flulike syndrome). Clinical
manifestations of acute Q fever in
these patients ranged from this flulike
syndrome (three patients), pneumoni-
tis (one patient), hepatitis (two
patients), pneumonitis and renal dys-
function (one patient), hepatitis and
renal dysfunction (one patient), to
severe myocarditis and acute renal
failure (one patient). An epidemic of
leptospirosis has been occurring in
Thailand since 1996 (7). All patients
in this study received a diagnosis of
either leptospirosis or acute fever of
undefined cause; therefore, empirical
therapy, including penicillin G sodi-
um, doxycycline, and cefotaxime or
ceftriaxone, was administered. The
patient with hepatic and renal dys-
function was treated with co-trimoxa-
zole. The patient who had severe
myocarditis and acute renal failure
was treated with a penicillin G sodium
and doxycycline combination. He also
received a dopamine infusion and
hemodialysis. The median duration
between admission and a reduction of
fever was 3 days (range 1–7) in this
case series.
Results of several seroprevalence
studies, using the complement fixa-
tion test, conducted in both humans
and animals suggest that C. burnetii
infection has been widespread in
Thailand since 1966 (8). The preva-
lence in asymptomatic persons varies
from 0.4% to 2.6% (9), and studies in
domestic animals show that the high-
est prevalence of this infection occurs
in dogs (28.1%). The prevalence in
goats, sheep, and cattle varies from
2.3% to 6.1% (9).However, this clini-
cal case series of acute Q fever is the
first diagnosed in this country. The
disease was diagnosed in patients in
four hospitals, situated in various
parts of the northeastern region of
Thailand. These data confirmed that
Q fever is widespread in this country.
The disease had been unrecognized
previously because the specific sero-
logic test was not widely available in
Thailand. 
A self-limited course was suspect-
ed in four cases in this series.
However, severe cases, especially
those with myocarditis, could be fatal.
Therefore, doxycycline should be an
empirical therapy for patients with
acute febrile illness in areas where
leptospirosis, scrub typhus, and acute
Q fever are suspected, such as in rural
Thailand. Further studies to investi-
gate the epidemiology of Q fever in
this country are needed. 
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Correction, Vol. 9, No. 8
In "Emerging Pathogen of Wild Amphibians in Frogs
(Rana catesbeiana) Farmed for International Trade," by
Rolando Mazzoni et al., errors occurred in the figure leg-
end on page 996. 
The correct caption to the Figure appears below:
Figure. a and b, histopathologic findings from infected
frogs. Characteristic sporangia (s) containing zoospores
(z) are visible in the epidermis (asterisk, superficial epi-
dermis; arrow, septum within an empty sporangium; bars,
10 µm). c, Skin smear from infected frog, stained with 1:1
cotton blue and 10% aqueous potassium hydroxide (aq
KOH) (D, developing stages of Batrachochytrium den-
drobatidis; arrow, septum within a sporangium; bar, 10
µm). d, Electron micrograph of an empty sporangium
showing diagnostic septum (arrow) (bar, 2 µm).
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Correction, Vol. 9, No. 8
In the article "NmcACarbapenem-hydrolyzing Enzyme
in  Enterobacter cloacae in North America," by Sudha
Pottumarthy et al., an error occurred the quality of the print-
ing of Figure 3.  Arevised figure appears below.  Acolor ver-
sion is available from: URL: http:// www.cdc.gov/ncidod/
EID/vol9no8/03-0096-G3.htm  
We regret any confusion this error may have caused.